Mayo Clinic And ASU Announce 6 Digital Health Startups For Its Inaugural MedTech Accelerator Cohort

Healthcare News

Mayo-Clinic_And-ASU-Announce-6-Digital-Health-Startups-For-Its-Inaugural-MedTech-Accelerator-Cohort Mayo Clinic And ASU Announce 6 Digital Health Startups For Its Inaugural MedTech Accelerator CohortThe collaborative effort of Mayo Clinic and Arizona State University (ASU), the MedTech Accelerator has announced the selection of 6 digital health startups for its inaugural cohort. The health startups include BioInteractive Technologies, GYANT, Hexoskin, Life365 Inc., Safe, and Securisyn. The MedTech Accelerator, a highly competitive, two-week program for entrepreneurial medical device and health systems, offer medical device and healthcare IT early-stage companies with personalized business development plans to work together with Mayo Clinic and ASU and stimulate go-to-market and investment opportunities.

The MedTech Accelerator will provide opportunities to participants to develop or optimize new products and services, authorize intellectual property, and support research and clinical studies. Participants will accomplish this through individually tailored development plans, a trusted MedTech Accelerator entrepreneurship curriculum, and idea mentoring and customer interactions within the healthcare environment. The MedTech Accelerator will begin with an immersion program on 22nd April to 3rd May at Mayo Clinic’s Arizona campus with ongoing activities that can be done remotely. The accelerator program will be completed within 6 to 12 months, with incentives, and will be offered to participants to stay and work in Arizona.

According to senior director of Health Innovation Programs at the ASU Edson College of Nursing and Health Innovation and ASU’s managing partner of the accelerator, Rick Hall, “After a nationwide competitive application process, we couldn’t be more pleased with this first group of participating companies. Hall further said that “The high level of applicants surpassed our expectations, providing us with a strong pool of MedTech companies with big potential for disruptive success.”